If your child's asthma symptoms are severe, your family doctor or pediatrician may refer your child to see an asthma specialist.
The doctor will want your child to take just the right amount and type of medication needed to control his or her asthma. This will help prevent side effects.
Based on your record of how well your child's current medications seem to be working, your child's doctor may "step up" treatment to a higher dose or add another type of medication. If your child's asthma is well controlled, the doctor may "step down" treatment by reducing your child's medications. This is known as the stepwise approach to asthma treatment.
As your child gets older, he or she can take more and more responsibility for watching symptoms and adjusting treatment.
Certain medications aren't specifically approved for use in children by the Food and Drug Administration, but the doctor may prescribe them based on his or her judgment of what's likely to work best for your child.
Long-term control medications
Known as maintenance medications, these are generally taken every day on a long-term basis to control persistent asthma. These medications may be used seasonally if your child's asthma symptoms become worse during certain times of the year.
Types of long-term control medications include:
- Inhaled corticosteroids. These are the most common long-term control medications for asthma. These anti-inflammatory drugs include fluticasone (Flovent HFA), budesonide (Pulmicort Flexhaler), flunisolide (Aerobid), ciclesonide (Alvesco), beclomethasone (Qvar) and mometasone (Asmanex).
- Leukotriene modifiers. These include montelukast (Singulair), zafirlukast (Accolate) and zileuton (Zyflo). They are considered a secondary addition to treatment with inhaled corticosteroids. In rare cases, these medications have been linked to psychological reactions such as agitation, aggression, hallucinations, depression and suicidal thinking. Seek medical advice right away if your child has any unusual psychological reaction.
- Combination inhalers. These medications contain an inhaled corticosteroid plus a long-acting beta agonist (LABA). They include the combinations fluticasone-salmeterol (Advair), budesonide-formoterol (Symbicort) and mometasone-formoterol (Dulera). In some situations, long-acting beta agonists have been linked to severe asthma attacks. LABA medications should only be given to children when they are combined with a corticosteroid in a combination inhaler. This reduces the risk of a severe asthma attack.
- Theophylline. This is a daily pill that opens the airways (bronchodilator). Theophylline (Theocron) is not used as often now as in past years.
Quick-relief 'rescue' medications
These medications — called short-acting bronchodilators — provide immediate relief of asthma symptoms and last four to six hours. Albuterol is the most commonly used short-acting bronchodilator for asthma. Others include pirbuterol and levalbuterol.
Although these medications work quickly, they can't keep your child's symptoms from coming back. If your child has frequent or severe symptoms, he or she will need to take a long-term control medication such as an inhaled corticosteroid.
Your child's asthma is not under control if he or she often needs to use a quick-relief inhaler. Relying on a quick-relief inhaler to control symptoms puts your child at risk of a severe asthma attack and is a sign that your child needs to see the doctor about making treatment changes.
Track the use of quick-relief medications, and share the information with your child's doctor at every visit.
Immunotherapy for allergy-induced asthma
Allergy-desensitization shots (immunotherapy) may help if your child has allergic asthma that can't be easily controlled by avoiding asthma triggers. Your child will begin with skin tests to determine which allergy-causing substances (allergens) may trigger asthma symptoms.
Once your child's asthma triggers are identified, he or she will often get a series of injections containing small doses of those allergens. Your son or daughter will probably need injections once a week for a few months, then once a month for a period of three to five years. Your child's allergic reactions and asthma symptoms should gradually diminish.
Medication delivery devices
Most asthma medications are given with a device that allows a child to breathe medication directly into the lungs. Your child's medication may be delivered with one of these devices:
- Metered dose inhaler. Small hand-held devices, metered dose inhalers are a common delivery method for asthma medication. To make sure your child gets the correct dose, he or she also may need a hollow tube (spacer) that attaches to the inhaler.
- Dry powder inhalers. For certain asthma medications, your child may have a dry powder inhaler. This device requires a deep, rapid inhalation to get the full dose of medication.
- Nebulizer. A nebulizer turns medications into a fine mist your child breathes in through a face mask. Nebulizers can deliver larger doses of medications into the lungs than inhalers can. Young children often need to use a nebulizer because it's difficult or impossible for them to use other inhaler devices.
Asthma control: Steps for children ages 12 and older
Managing asthma can seem like an overwhelming responsibility. Following these steps makes it a lot easier.
Learn about asthma
A critical part of managing your child's asthma is learning exactly what steps to take on a daily, weekly, monthly and yearly basis. It's also important that you understand the purpose of each part of tracking symptoms and adjusting treatment. You, your child and caretakers need to:
- Understand the different types of medications for asthma and how they work
- Learn to recognize and record signs and symptoms of worsening asthma
- Know what to do when your child's asthma gets worse
Track symptoms with a written plan
A written asthma action plan is an important tool to let you know how well treatment is working, based on asthma symptoms. With your child's doctor, create a written asthma plan that outlines the steps needed to manage asthma. You and your child's caretakers, including relatives, teachers, school nurses and coaches, should have a copy of the plan.
The plan can help you and your child:
- Track how often your child has asthma flare-ups (exacerbations)
- Judge how well medications are controlling symptoms
- Note any medication side effects
- Check how well your child's lungs are working with a peak flow meter
- Measure how much your child's symptoms affect daily activities such as sleep and sports
- Adjust medications when symptoms get worse
- Recognize when to see a doctor or seek emergency care
Many asthma plans use a "stoplight" system of green, yellow and red zones that correspond to worsening symptoms. This system can help you quickly determine asthma severity and identify signs of an asthma attack. Some asthma plans use a symptoms questionnaire called the Asthma Control Test to measure asthma severity over the past month.
Make changes and see the doctor when necessary
Effective asthma treatment requires tracking how well medications are working on an ongoing basis — and knowing what to do when they're not working. You and your child need to:
- Work with the doctor to determine what types and doses of medications are most effective
- Adjust medications according to the asthma action plan you worked out with your child's doctor
- Watch for side effects such as irritability, shaking or trouble sleeping, and report them to the doctor
Control asthma triggers
Taking steps to help your child avoid triggers is an important part of controlling asthma. Asthma triggers vary from child to child. Work with your child's doctor to identify triggers and what steps you can take to help your child avoid them.
Common asthma triggers include:
- Colds or other respiratory infections
- Allergens such as dust mites or pollen
- Pet dander
- Cold weather
- Cigarette smoke and other irritants in the air
- Severe heartburn (gastroesophageal reflux or GERD)
The key to asthma control: Follow the action plan
Following and updating an asthma action plan is the key to keeping symptoms under control. Older children should take increasing responsibility for using the plan and discussing asthma with the doctor.
Work with your child to carefully track symptoms, and make medication changes as soon as they're needed. By acting quickly, you and your child can prevent a severe attack and he or she won't need as much medication to control symptoms.
With careful asthma management, your child should be able to avoid flare-ups and minimize disruptions caused by asthma.
Feb. 11, 2014
See more In-depth
- Expert panel report 3 (EPR3): Guidelines for the diagnosis and management of asthma. Bethesda, Md.: National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/guidelines/asthma/. Accessed June 23, 2013.
- Childhood asthma: Tips to remember. American Academy of Allergy, Asthma & Immunology. http://www.aaaai.org/conditions-and-treatments/library/at-a-glance/childhood-asthma.aspx. Accessed July 24, 2013.
- Childhood asthma. Asthma and Allergy Foundation of America. http://www.aafa.org/display.cfm?id=8&sub=16&cont=44. Accessed July 24, 2013.
- Bope ET, et al. Conn's Current Therapy. Philadelphia, Pa.: Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed July 24, 2013.
- Sawicki G, et al. Chronic asthma in children younger than 12 years: Evaluation and diagnosis. www.uptodate.com/home. Accessed July 24, 2013.
- Sawicki G, et al. Chronic asthma in children younger than 12 years: Controller medications. www.uptodate.com/home. Accessed July 24, 2013.
- Updated information on leukotriene inhibitors: Montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR). U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165489.htm. Accessed July 25, 2013.
- Diagnosis and Management of Asthma Guideline. Bloomington, MN. Institute for Clinical Systems Improvement. http://mayoweb.mayo.edu/etc-ame/icsi/Asthma.pdf. Accessed Aug. 3, 2013.